[Clinical experiences with intracervical prostaglandin E2 administration for labor induction]

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Clinical Pharmacology

Context:

• Prospective study conducted from 1986-1987 involving 119 patients requiring labor induction.
• Patients were categorized into three groups based on indications: mixed, premature rupture of membranes, and medical reasons.
• Compared outcomes between multiparous and nulliparous women, and analyzed results based on cervical ripeness.

Purpose:

• To evaluate the efficacy and safety of intracervical prostaglandin E2 (PGE2) gel for labor induction.
• To assess factors influencing induction success, labor duration, and Cesarean section rates.
• To identify potential risks and side effects associated with PGE2 induction.

Summary:

• Overall, 66.4% of patients achieved delivery within 24 hours of the first PGE2 gel application.
• Multiparous women demonstrated significantly better outcomes regarding induction success, labor duration, and Cesarean section rates compared to nulliparous women.
• Repeated induction attempts were associated with increased Cesarean sections, fever, and prolonged labor. Side effects were minimal, with one case of uterine rupture being the most severe complication.

Impact:

• Intracervical PGE2 application for labor induction is a viable option, showing no disadvantage to mother or fetus when used with defined indications and criteria.
• Findings support the use of PGE2 gel as a safe and effective method for labor induction in selected obstetric populations.
• The study highlights the importance of patient parity and cervical status in predicting successful labor induction outcomes.